Stocktoria
P3 Health Partners Inc. PIII
Nasdaq · stock · Services-Health Services · website · IPO 2021-02-10
P3 Health Partners Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.3B | $1.0B | $491.1M |
| Operating income | -$270.3M | -$320.7M | -$167.9M | -$1.6B | -$28.6M |
| Income tax | $2.0M | $4.4M | $2.7M | $1.9M | $0 |
| Net income | -$147.9M | -$135.8M | -$57.8M | -$270.1M | -$31.4M |
| EPS (diluted) | $-45.26 | $-54.06 | $-0.63 | $-6.50 | — |
| Operating cash flow | -$91.2M | -$110.1M | -$76.0M | -$126.0M | -$24.6M |
| Free cash flow | — | -$110.1M | -$77.9M | -$128.3M | -$27.5M |
| Cash & equivalents | $25.0M | $38.8M | $36.3M | $17.5M | $36.3M |
| Total assets | $656.6M | $783.4M | $861.0M | $876.6M | $106.4M |
| Total liabilities | $796.9M | $633.9M | $427.3M | $353.9M | $146.0M |
| Shareholders' equity | -$155.2M | $75.9M | $142.1M | $5.9M | $22,714 |
Growth · year-over-year · Revenue CAGR 31.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue growth | -2.8% | +18.5% | +20.7% | +113.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.